Drugs

Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer
pp. 255-261(7)
Authors: Saylor, Philip J.; Keating, Nancy L.; Freedland, Stephen J.; Smith, Matthew R.

Drugs in Development for Viral Hepatitis: Care and Caution
pp. 263-271(9)
Author: Pockros, Paul J.

The Role of Dopamine Agonists in the Treatment of Depression in Patients with Parkinson's Disease: A Systematic Review
pp. 273-286(14)
Author: Leentjens, Albert F.G.

Non-Hormonal Treatment Strategies for Vasomotor Symptoms: A Critical Review
pp. 287-304(18)
Authors: Hall, Elise; Frey, Benicio N.; Soares, Claudio N.

Current Options and New Developments in the Treatment of Haemophilia
pp. 305-320(16)
Authors: Wong, Trisha; Recht, Michael

Current and Emerging Pharmacological Treatments for Gastrointestinal Stromal Tumour
pp. 321-330(10)
Authors: Ganjoo, Kristen N.; Patel, Shreyaskumar

Treatment of Viral Conjunctivitis with Antiviral Drugs
pp. 331-347(17)
Authors: Skevaki, Chrysanthi L.; Galani, Ioanna E.; Pararas, Michail V.; Giannopoulou, Konstantina P.; Tsakris, Athanassios

Sitagliptin/Metformin Fixed-Dose Combination: In Patients with Type 2 Diabetes Mellitus
pp. 349-361(13)
Author: Chwieduk, Claudine M.

Fulvestrant: A Review of its Use in the Management of Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women
pp. 363-380(18)
Authors: Croxtall, Jamie D.; McKeage, Kate

Erratum
pp. 381-381(1)